PL2675454T3 - Sposoby kontrolowania bólu u koniowatych przy zastosowaniu przezskórnego roztworu fentanylu - Google Patents

Sposoby kontrolowania bólu u koniowatych przy zastosowaniu przezskórnego roztworu fentanylu

Info

Publication number
PL2675454T3
PL2675454T3 PL12704489T PL12704489T PL2675454T3 PL 2675454 T3 PL2675454 T3 PL 2675454T3 PL 12704489 T PL12704489 T PL 12704489T PL 12704489 T PL12704489 T PL 12704489T PL 2675454 T3 PL2675454 T3 PL 2675454T3
Authority
PL
Poland
Prior art keywords
equines
fentanyl
methods
controlling pain
transdermal solution
Prior art date
Application number
PL12704489T
Other languages
English (en)
Inventor
Amy Louise Marr
Douglas Eugene Mouzin
Jane Granville Owens
Kari Lynette Riggs
Original Assignee
Audevard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Audevard filed Critical Audevard
Publication of PL2675454T3 publication Critical patent/PL2675454T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017Non-human animal skin, e.g. pour-on, spot-on
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K13/00Devices for grooming or caring of animals, e.g. curry-combs; Fetlock rings; Tail-holders; Devices for preventing crib-biting; Washing devices; Protection against weather conditions or insects
    • A01K13/003Devices for applying insecticides or medication
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61DVETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D7/00Devices or methods for introducing solid, liquid, or gaseous remedies or other materials into or onto the bodies of animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4468Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Environmental Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Pest Control & Pesticides (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL12704489T 2011-02-15 2012-02-08 Sposoby kontrolowania bólu u koniowatych przy zastosowaniu przezskórnego roztworu fentanylu PL2675454T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161442878P 2011-02-15 2011-02-15
PCT/US2012/024252 WO2012112355A1 (en) 2011-02-15 2012-02-08 Methods for controlling pain in equines using a transdermal solution of fentanyl
EP12704489.9A EP2675454B1 (en) 2011-02-15 2012-02-08 Methods for controlling pain in equines using a transdermal solution of fentanyl

Publications (1)

Publication Number Publication Date
PL2675454T3 true PL2675454T3 (pl) 2020-10-05

Family

ID=45615079

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12704489T PL2675454T3 (pl) 2011-02-15 2012-02-08 Sposoby kontrolowania bólu u koniowatych przy zastosowaniu przezskórnego roztworu fentanylu

Country Status (10)

Country Link
US (1) US20120322828A1 (pl)
EP (1) EP2675454B1 (pl)
JP (1) JP2014505727A (pl)
BR (1) BR112013020604A2 (pl)
CA (1) CA2827488C (pl)
EA (1) EA022648B1 (pl)
ES (1) ES2784627T3 (pl)
MX (1) MX2013009467A (pl)
PL (1) PL2675454T3 (pl)
WO (1) WO2012112355A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH705153A1 (fr) * 2011-06-24 2012-12-31 Heidi Hall Mors et système pour envoyer une substance visqueuse et/ou liquide dans la bouche d'un animal.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6916486B2 (en) * 1996-02-19 2005-07-12 Acrux Dds Pty Ltd Transdermal delivery of analgesics
AUPN814496A0 (en) 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
JP5160018B2 (ja) * 2002-06-25 2013-03-13 アクルックス・ディ・ディ・エス・プロプライエタリー・リミテッド 非晶質医薬組成物を用いる経皮送達速度調節
AUPS317102A0 (en) * 2002-06-25 2002-07-18 Drug Delivery Solutions Pty Ltd Transdermal aerosol compositions
EP1694400A1 (en) * 2003-11-28 2006-08-30 Acrux DDS Pty Ltd Method and system for rapid transdermal administration
DE112006002834T5 (de) * 2005-11-04 2008-10-30 Acrux DDS Pty. Ltd., West Melbourne Verfahren und System für eine transdermale Arzneimittelzufuhr
WO2009047779A2 (en) * 2007-06-20 2009-04-16 Nikki Nikhilesh Singh Composition containing fentanyl base aromatic oils and alkyl salicylate for the delivery of fentanyl base in vapour form
US20110092922A1 (en) * 2009-10-19 2011-04-21 Trompen Mick A Transdermal dispensing apparatus and methods

Also Published As

Publication number Publication date
EP2675454A1 (en) 2013-12-25
MX2013009467A (es) 2013-09-06
ES2784627T3 (es) 2020-09-29
CA2827488C (en) 2020-07-07
BR112013020604A2 (pt) 2016-10-18
CA2827488A1 (en) 2012-08-23
EP2675454B1 (en) 2020-01-22
JP2014505727A (ja) 2014-03-06
US20120322828A1 (en) 2012-12-20
EA201391001A1 (ru) 2013-12-30
WO2012112355A1 (en) 2012-08-23
EA022648B1 (ru) 2016-02-29

Similar Documents

Publication Publication Date Title
EP2680918A4 (en) TRANSDERMAL STAMP CONTAINING MICROARRAYS
EP2717958A4 (en) TRANSDERMALE DEVICE WITH MICRONED PINS
EP2720719A4 (en) METHOD FOR SELECTION OF THERAPEUTIC INDICATIONS
HRP20190023T1 (hr) Pripravak za kontroliranu stimulaciju jajnika
GB201110095D0 (en) Method of treatment
EP2773754A4 (en) Methods of Treatment
HRP20260473T1 (hr) Metoda generiranja rekonstruiranog bloka
EP2675458A4 (en) COMPOUNDS AND METHOD FOR TREATING BLOOD HIGH PRESSURE
PL2705186T3 (pl) Sposób wytwarzania igłowanego wodnie materiału włókninowego
EP2771091A4 (en) CONTROL DEVICE AND METHOD FOR OPERATING A CAPACITIVE DEIONIZATION SYSTEM
IL230433A0 (en) Pain management methods
IL232292A0 (en) Preparations containing a substance with anti-conoxin activity and their use for increasing anti-conoxin activity and their use for increasing the activity of acetylcholinesterase inhibitors
EP2745235A4 (en) METHOD FOR REPOSITIONING MEDICATION
ZA201403497B (en) Transdermal therapeutic system for administering fentanyl or analogue thereof
ZA201403739B (en) Methods of treatment with deferiprone
EP2915924A4 (en) DEVICE AND METHOD FOR CONTROLLING THE SWING OF A BUILDING MACHINE
EP2753395A4 (en) METHOD AND DEVICE FOR TRANSDERMAL DELIVERY OF SUBSTANCES
ZA201502595B (en) Therapeutic methods
ZA201200851B (en) Anti-wart pharmaceutical composition and method for treating wart
ZA201305341B (en) Methods for controlling pain in canines using a transdermal solution of fentanyl
EP2662092A4 (en) METHOD FOR SELECTING PATIENTS FOR THE ADMINISTRATION OF MEDICAMENTS FOR THE TREATMENT OF SEPSIS
EP2723015A4 (en) METHOD AND DEVICE FOR COMMUNICATING GRANULARITY OF PARAMETERS
HK1188932A (en) Methods for controlling pain in canines using a transdermal solution of fentanyl
BR112013020604A2 (pt) métodos para controlar a dor em equinos usando uma solução transdérmica de fentanil
EP2791324A4 (en) PROCESSING METHOD